Irving, TX, United States of America

Xinlin Du

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Peloton Therapeutics, Inc.. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Xinlin Du in Treating Pulmonary Arterial Hypertension

Introduction

Xinlin Du is an accomplished inventor based in Irving, TX (US). He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary arterial hypertension (PAH). His innovative work has led to the development of effective methods and compositions aimed at addressing this serious health condition.

Latest Patents

Xinlin Du holds 1 patent for his invention titled "Compositions for use in treating pulmonary arterial hypertension." This patent outlines methods for treating PAH in subjects who require such intervention. The compositions provided in this patent are designed to enhance the treatment options available for patients suffering from this condition.

Career Highlights

Xinlin Du is currently employed at Peloton Therapeutics, Inc., where he continues to advance his research and development efforts. His work at Peloton Therapeutics has positioned him as a key player in the pharmaceutical industry, focusing on innovative solutions for complex medical challenges.

Collaborations

Throughout his career, Xinlin Du has collaborated with notable colleagues, including John A. Josey and Eli M. Wallace. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking treatments.

Conclusion

Xinlin Du's contributions to the field of pulmonary arterial hypertension treatment exemplify the impact of innovation in medicine. His patent and ongoing work at Peloton Therapeutics highlight the importance of research and collaboration in developing effective therapies for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…